A prospective, multicenter, phase II trial of albumin-paclitaxel plus cisplatin versus gemcitabine plus cisplatin in first-line treatment of advanced biliary tract tumors
Yang Xiao,Zhuang Liang,Dai Yuhong,et al.A prospective, multicenter, phase II trial of albumin-paclitaxel plus cisplatin versus gemcitabine plus cisplatin in first-line treatment of advanced biliary tract tumors[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
APA:
Yang, Xiao,Zhuang, Liang,Dai, Yuhong,Qiu, Hong&Yuan, Xianglin.(2022).A prospective, multicenter, phase II trial of albumin-paclitaxel plus cisplatin versus gemcitabine plus cisplatin in first-line treatment of advanced biliary tract tumors.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA:
Yang, Xiao,et al."A prospective, multicenter, phase II trial of albumin-paclitaxel plus cisplatin versus gemcitabine plus cisplatin in first-line treatment of advanced biliary tract tumors".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)